NCT06278883 2026-04-09
GRACE
Duke University
Phase NA Completed
Clinical Trials
77 trialsNCT06096779 2026-04-03
Kirros
Genentech, Inc.
Phase 2 Recruiting
NCT06600321 2026-03-31
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Alnylam Pharmaceuticals
Phase 1 Recruiting
NCT07377487 2026-03-30
INDIGO
Boston Scientific Corporation
Phase NA Recruiting
NCT05063565 2026-03-27
ROWAN
Boston Scientific Corporation
Phase 2 Active not recruiting
NCT05953337 2026-03-04
Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)
ABK Biomedical
Phase NA Active not recruiting
NCT05196867 2026-02-24
Liver Cancer Prevention Randomized Control Trial
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT06535399 2026-01-23
Study to Assess Drug Levels and Safety of Golcadomide (BMS-986369) in Healthy Participants and Participants With Different Degrees of Hepatic Impairment
Celgene
Phase 1 Completed
NCT04618692 2025-12-18
Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver Transplantation
Istanbul Medipol University Hospital
Phase NA Completed
NCT07191548 2025-10-10
LIVERMET-IRE
Angiodynamics, Inc.
Phase NA Not yet recruiting
NCT06352528 2025-10-06
A Study to Assess the Drug Levels of Repotrectinib in Healthy Participants and Participants With Moderate and Severe Hepatic Impairment
Bristol-Myers Squibb
Phase 1 Completed
NCT04727307 2025-09-30
AB-LATE02
University Hospital, Montpellier
Phase 2 Recruiting
NCT07111130 2025-09-23
RE-BALANCE
National Cancer Centre, Singapore
Phase NA Not yet recruiting
NCT07185360 2025-09-22
LIVER-TRACK
Assistance Publique - HĂ´pitaux de Paris
Phase NA Not yet recruiting
NCT07150624 2025-09-02
The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine
Anhui Provincial Hospital
Phase 4 Recruiting
NCT02312817 2025-07-15
RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health System
University of Texas Southwestern Medical Center
Phase NA Completed
NCT01047735 2025-07-11
TRIABETES
University of Pittsburgh
Phase NA Active not recruiting
NCT07053488 2025-07-08
CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
Phase 1/2 Recruiting
NCT05339984 2025-06-27
LSM
Assistance Publique - HĂ´pitaux de Paris
Phase NA Recruiting
NCT06425198 2025-01-22
Study to Assess Drug Levels and Safety of BMS-986278 in Healthy Participants and Participants With Different Degrees of Hepatic Impairment
Bristol-Myers Squibb
Phase 1 Completed
NCT06526754 2024-12-18
Feasibility Analysis of LCD-SLA 3D Printing Technology for Overall Surgical Planning of Liver Malignant Tumors
Affiliated Hospital of Hebei University
Phase NA Completed
NCT04926376 2024-11-29
Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC)
ABK Biomedical
Phase NA Completed
NCT06126419 2024-11-20
Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase NA Recruiting
NCT06061276 2024-09-23
bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC
Sun Yat-sen University
Phase NA Recruiting
NCT03519074 2024-09-19
Cisplatin Combined with Oral TS-1 in Patients with Advanced Solid Tumors with Different Degrees of Liver Dysfunction
National University Hospital, Singapore
Phase 2 Active not recruiting
NCT02301104 2024-09-05
A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment
Taiho Oncology, Inc.
Phase 1 Completed
NCT03814005 2024-09-05
A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems
Takeda
Phase 1 Completed
NCT02112656 2024-08-20
OPTIMA
Imunon
Phase 3 Completed
NCT06070636 2024-08-09
bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma
Sun Yat-sen University
Phase NA Recruiting
NCT00113113 2024-08-02
Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction
Astex Pharmaceuticals, Inc.
Phase 1 Completed
NCT04518852 2024-06-25
TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC
Sichuan Cancer Hospital and Research Institute
Phase 2 Completed
NCT02508467 2024-04-12
A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma
Blueprint Medicines Corporation
Phase 1 Completed
NCT04185454 2023-01-11
Estimation of Minimum Efficacy Daily Dose of Jarlsberg Cheese
Meddoc
Phase NA Completed
NCT05662813 2022-12-23
Almonertinib Therapy in Patients With Abnormal Liver Function After EGFR-TKI Treatment, or Almonertinib First-line Therapy in Patients With Basic Hepatopathy
West China Hospital
Phase 2 Unknown
NCT04172714 2022-12-06
Low-dose Y90 Treatment Planning for HCC
Emory University
Phase NA Completed
NCT04666558 2022-10-04
PiONEeR
University of Alberta
Phase NA Completed
NCT01429038 2022-06-14
Mesenchymal Stem Cells After Renal or Liver Transplantation
University of Liege
Phase 1/2 Completed
NCT04639115 2022-06-14
A Phase 1, Multicenter, Open-Label Study to Evaluate the Effect of Mild or Moderate Hepatic Impairment on the Multiple-Dose Pharmacokinetics of Ozanimod
Celgene
Phase 1 Completed
NCT04825470 2022-03-11
TRANSGIST
Hospital Universitario Virgen de la Arrixaca
Phase NA Unknown
NCT05084456 2021-10-19
Oral Docetaxel in Patients With Normal or Impaired Liver Function
Modra Pharmaceuticals
Phase 1 Withdrawn
NCT02292173 2021-06-10
Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT00543777 2021-04-13
Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT03008512 2021-02-04
A Phase II Study of Weekly Genexol-PM in Patients With Hepatocelluar Carcinoma After Failure of Sorafenib
Gachon University Gil Medical Center
Phase 2 Terminated
NCT04640116 2020-12-19
TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites
Sun Yat-sen University
Phase NA Unknown
NCT04437953 2020-12-08
Avatrombopag for Thrombocytopenia in People With Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Withdrawn
NCT03289533 2020-09-04
A Study Of Avelumab In Combination With Axitinib In Advanced HCC (VEGF Liver 100)
Pfizer
Phase 1 Completed
NCT01871545 2020-07-09
Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI)
Icahn School of Medicine at Mount Sinai
Phase NA Completed
NCT02989870 2020-06-05
Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Withdrawn
NCT02868242 2020-03-02
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy
Gilead Sciences
Phase 2 Completed
NCT01273155 2019-03-26
Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction
National Institutes of Health Clinical Center (CC)
Phase 1 Completed